A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Silverback Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 3,506 shares of SBTX stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,506
Previous 2,893 21.19%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
N/A
613 Added 21.19%
3,506 $0
Q2 2024

Jul 30, 2024

BUY
N/A
2,893 New
2,893 $0
Q4 2023

Jan 24, 2024

BUY
N/A
152 Added 0.93%
16,534 $0
Q3 2023

Oct 26, 2023

BUY
N/A
102 Added 0.63%
16,382 $0
Q2 2023

Aug 10, 2023

BUY
N/A
16,280 New
16,280 $0

Others Institutions Holding SBTX

About Silverback Therapeutics, Inc.


  • Ticker SBTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,473,800
  • Description
  • Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverba...
More about SBTX
Track This Portfolio

Track Mirae Asset Global Investments Co., Ltd. Portfolio

Follow Mirae Asset Global Investments Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.